VVOS (Vivos Therapeutics, Inc) Company Projected Revenue

Brandmark of Vivos Therapeutics, Inc (VVOS)

Vivos Therapeutics (VVOS) management is implementing non-surgical apnea treatments while expanding its clinic network. Revenue forecasts provided by GURU.Markets data confirm this growth, with the indicator currently standing at 0.02. High demand for unique biomimetic treatment provides pricing power, while a narrow specialization in dental devices is offset by the active implementation of insurance systems.

VVOS - Vivos Therapeutics Inc Company Expected Sales Volume over the range 07/04/2022 - 11/17/2026

Analytical breakdowns and data insights for company Vivos Therapeutics, Inc (VVOS)

- current price and projected stock value:
Fundamental company analysis:vivoslife.com
Brand item of Vivos Therapeutics Inc.

Vivos Therapeutics' partnership with dental clinics creates a sustainable distribution channel for apnea therapy systems. This operational stability directly forms the mathematical basis for projected revenue. This metric quantifies expected cash inflows, allowing management's promises to be verified through market data. Trend analysis reveals the actual quality of commercial scaling. A steady increase in the company's planned sales volume confirms organic growth, whereas suspiciously smooth lines may indicate the manipulation of expectations.

Analysis of competing companies

Company Projected Revenue Boston Scientific Corp (BSX)|EW - Company Expected Sales Volume|Projected Sales Volume RMD (resmed.com)|PODD - Company Future Sales Volume|Zimmer Biomet Holdings, Inc. - Projected Sales Volume|COO (The Cooper Companies) - Company Revenue Forecast|ALGN: Projected Sales Volume|Company Revenue Forecast GMED|TMDX (TransMedics Corp) - Projected Sales Volume|ATEC Spine (ATEC) - Company Future Sales|Projected Sales Volume AORT|Company Future Sales Volume Enovis Corporation ENOV|Projected Sales Volume IART (integralife.com)|Projected Sales Volume Establishment Labs Corp ESTA|BBNX - Company Projected Revenue|IRMD: Company Projected Revenue|EMBC (Embecta Corp.) - Company Future Sales Volume|Tandem Diabetes Care - Company Future Revenue|AXGN (Axogen Surgical) - Projected Sales Volume|Company Expected Sales Volume SI-BONE Inc SIBN|Company Projected Revenue Orthofix Medical (OFIX)|Projected Sales Volume Bioventus Corp (BVS)|OrthoPediatrics Corp - Company Future Sales Volume|Projected Sales Volume Treace Medical Concepts TMCI|Blade Air Mobility - Projected Sales Volume|Company Future Sales Carlsmed, Inc. CARL|RxSight (RXST) - Company Projected Revenue|Company Expected Revenue CLPT (ClearPoint)|Company Projected Revenue stereotaxis.com|Company Future Sales Volume Neuronetics, Inc. (STIM)|Projected Sales Volume SGHT|OBIO - Company Expected Sales Volume|Company Projected Revenue anikatherapeutics.com ANIK|NSPR: Company Revenue Forecast|ZJYL: Company Future Sales Volume|Vivani Medical Inc - Company Projected Revenue Volume|XTNT (Xtant Medical Holdings) - Company Future Sales Volume|Company Revenue Forecast NMTC|Company Projected Revenue Modular Medical Inc|Company Expected Sales Volume Myomo Inc MYO|Company Future Sales Volume COCH (Envoy Medical, Inc.)|Company Projected Revenue NVNO (enVVeno Medical Corp.)|Sintx Technologies, Inc. - Company Future Sales Volume|Tenon Medical Inc. (TNON) - Company Expected Sales Volume|LFWD - Company Projected Revenue|AMIX (Autonomix Medical) - Company Revenue Forecast|IVF: Projected Sales Volume|BBLG (Bone Biologics) - Company Projected Revenue|Company Projected Revenue Axonics Inc.|Company Expected Sales Volume Biolase, Inc. BIOL|Company Projected Revenue Dynatronics Corp. (DYNT)|FNA (Paragon 28 Corp) - Company Future Revenue|Company Projected Revenue invobioscience.com INVO